Search Results - "Sukumaran, Shawgi"

Validation of a Short Food Frequency Questionnaire to Measure Dietary Intake of a Selection of Micronutrients in Oncology Patients Undergoing Systemic Therapy by Mukherjee, Mitali S, Sukumaran, Shawgi, Delaney, Christopher L, Miller, Michelle D

“…Dietary intake, specifically consumption of anti-inflammatory micronutrients, can play a role in both cancer initiation as well as the treatment-related…”
Get full text

Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy by Murray-Brown, William, Wilsdon, Tom D, Weedon, Helen, Proudman, Susanna, Sukumaran, Shawgi, Klebe, Sonja, Walker, Jennifer G, Smith, Malcolm D, Wechalekar, Mihir D

“…BackgroundImmune checkpoint inhibitors (ICIs) are associated with rheumatic and musculoskeletal immune-related adverse events (irAEs) in 5%–20% of patients…”
Get full text

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer by Abbas, M. Nazim, Klevansky, Myron, Koczwara, Bogda, Roy, Amitesh Chandra, Sukumaran, Shawgi, Vatandoust, Sina, Karapetis, Christos Stelios

“…Background Nivolumab improves disease control and survival in advanced NSCLC in patients with good performance status (PS), but there is limited data on its…”
Get full text

Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study by Martin, Hilary Laura, Ullah, Shahid, Abbas, Nazim, Scott‐Hoy, Alex, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Roy, Amitesh, Sukumaran, Shawgi, Ross, David M, Khattak, Muhammad Adnan, Koczwara, Bogda

“…Background Chemotherapy can cause premature menopause which may result in adverse effects such as fertility loss, osteoporosis, cardiovascular disease and…”
Get full text

Feasibility of cancer treatment without blood transfusion in Jehovah’s Witnesses by Chang, Rachael, Sukumaran, Shawgi

“…Abstract only…”
Get full text

Tocilizumab in grade 4 hepatitis secondary to immune checkpoint inhibitor: a case report and review of the literature by Ali, Syed B, Vembar, Preethi, Sukumaran, Shawgi, Gunawardane, Dimuth, Hughes, Tiffany, Smith, Anthony

“…First- and second-line treatments for immune checkpoint inhibitor-related hepatotoxicity (IRH) are well established; however, evidence for third-line therapies…”
Get full text

Effect of anti-inflammatory diets on inflammation markers in adult human populations: a systematic review of randomized controlled trials by Mukherjee, Mitali S, Han, Chad Y, Sukumaran, Shawgi, Delaney, Christopher L, Miller, Michelle D

“…Chronic inflammation, characterized by prolonged elevated inflammation markers, is linked to several chronic conditions. Diet can influence the levels of…”
Get full text

An open-label, multicenter, phase 2 study of the safety and efficacy of navtemadlin (KRT-232) in patients with TP53 wild-type relapsed/refractory small cell lung cancer by Dowlati, Afshin, Juan-Vidal, Oscar, Hiret, Sandrine, Rittmeyer, Achim, Sukumaran, Shawgi, Vicente Baz, David, Rios-Perez, Jorge Arturo, Harris, Eric Michael, McCune, Steven L., Johnson, Melissa Lynne, Croft, Brandon, McGreivy, Jesse S., Rothbaum, Wayne P., de Castro Carpeño, Javier

“…TPS8600 Background: Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor characterized by early metastasis and a high recurrence rate with…”
Get full text

Online information and support needs of women with advanced breast cancer: a qualitative analysis by Kemp, Emma, Koczwara, Bogda, Butow, Phyllis, Turner, Jane, Girgis, Afaf, Schofield, Penelope, Hulbert-Williams, Nicholas, Levesque, Janelle, Spence, Danielle, Vatandoust, Sina, Kichenadasse, Ganessan, Roy, Amitesh, Sukumaran, Shawgi, Karapetis, Christos S., Richards, Caroline, Fitzgerald, Michael, Beatty, Lisa

“…Purpose Women with advanced breast cancer (ABC) face significant adjustment challenges, yet few resources provide them with information and support, and…”
Get full text

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy by Berry, Ella C., Mullany, Sean, Quinlivan, Alannah, Craig, Amelia, New-Tolley, Julia, Slattery, James, Sukumaran, Shawgi, Klebe, Sonja, Craig, Jamie E., Siggs, Owen M., Wechalekar, Mihir D.

“…Immune checkpoint inhibitor therapy is frequently associated with immune-related adverse events, which occasionally manifest with visual symptoms. Here, we…”
Get full text

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy by Berry, Ella C., Mullany, Sean, Quinlivan, Alannah, Craig, Amelia, New-Tolley, Julia, Slattery, James, Sukumaran, Shawgi, Klebe, Sonja, Craig, Jamie E., Siggs, Owen M., Wechalekar, Mihir D.

“…Immune checkpoint inhibitor therapy is frequently associated with immune-related adverse events, which occasionally manifest with visual symptoms. Here, we…”
Get full text

Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head and neck (H&N) cancer by Osei-Fofie, Daniel, Wetter, Julie, Landers, Greg A., Kraus, Peter Alfred, Sukumaran, Shawgi, Mun, Hui, Stein, Brian N., Bray, Victoria Jane, Framroze, Bomi, Gelfand, Jeffrey, Song, Paul Y., Lategan, Andries, Dimitriu, Mikaela, Sonis, Stephen T.

“…Abstract only 6075 Background: OM is a common, painful, and costly toxicity associated with cytotoxic regimens used to treat H&N cancers, which may result in…”
Get full text

Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma by Roy, Amitesh Chandra, Abbas, M. Nazim, Price, Timothy Jay, Singhal, Nimit, Vatandoust, Sina, Leung, John, Kichenadasse, Ganessan, Koczwara, Bogda, Sukumaran, Shawgi, Kumar, Rajiv, Woodman, Richard, Scott-Hoy, Alex, Karapetis, Christos Stelios

Get full text

Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma by Roy, Amitesh Chandra, Abbas, M. Nazim, Price, Timothy Jay, Singhal, Nimit, Vatandoust, Sina, Leung, John, Kichenadasse, Ganessan, Koczwara, Bogda, Sukumaran, Shawgi, Kumar, Rajiv, Woodman, Richard, Scott-Hoy, Alex, Karapetis, Christos Stelios

“…Nab-paclitaxel has radiosensitizing antitumor efficacy in pancreatic cancer. We aimed to establish maximum tolerated dose (MTD) of nab-paclitaxel with…”
Get full text

Phase I trial of nab-paclitaxel administered concurrently with radiotherapy in patients with locally advanced inoperable pancreatic adenocarcinoma (ART in LAP) by Roy, Amitesh Chandra, Abbas, Muhammad Nazim, Price, Timothy Jay, Singhal, Nimit, Vatandoust, Sina, Leung, John, Kichenadasse, Ganessan, Koczwara, Bogda, Sukumaran, Shawgi, Kumar, Rajiv, Woodman, Richard John, Richards, Alison, Scott-Hoy, Alex, Karapetis, Christos Stelios

“…Abstract only e16796 Background: Locally advanced pancreatic adenocarcinoma (LAPC) carries a poor prognosis with median overall survival of 12-18m. The optimal…”
Get full text

Outcomes of solid tumor malignancies in patients of Jehovah’s Witness faith by Chang, Rachael, Sukumaran, Shawgi, Woodman, Richard John, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Koczwara, Bogda, Vatandoust, Sina, Roy, Amitesh Chandra

“…Abstract only e18176 Background: Jehovah's Witness (JW) patients with cancer present unique challenges due to their refusal of blood and blood products which…”
Get full text

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination by Millward, Michael, Price, Timothy, Townsend, Amanda, Sweeney, Christopher, Spencer, Andrew, Sukumaran, Shawgi, Longenecker, Angie, Lee, Lonnie, Lay, Ana, Sharma, Girish, Gemmill, Robert M., Drabkin, Harry A., Lloyd, G. Kenneth, Neuteboom, Saskia T. C., McConkey, David J., Palladino, Michael A., Spear, Matthew A.

“…Summary Purpose Combining proteasome and histone deacetylase (HDAC) inhibition has been seen to provide synergistic anti-tumor activity, with complementary…”
Get full text

A prospective study of anti-mullerian hormone (AMH) as a predictor of chemotherapy-induced menopause by Koczwara, Bogda, Ullah, Shahid, Abbas, M Nazim, Scott-Hoy, Alex, Young, Fiona, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Roy, Amitesh Chandra, Sukumaran, Shawgi, Ross, David M., Khattak, Muhammad Adnan, Atkinson, Elinor, Martin, Hilary

“…Abstract only e23076 Background: Chemotherapy-induced premature menopause is a distressing side effect of cancer treatment. Currently there are no validated…”
Get full text

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)—cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years by Padman, Sunita, Lee, Jaein, Kumar, Rajiv, Slee, Mark, Hakendorf, Paul, Richards, Alison, Koczwara, Bogda, Kichenadasse, Ganessan, Sukumaran, Shawgi, Roy, Amitesh, Vatandoust, Sina, Karapetis, Christos S.

“…Objectives Oxaliplatin accumulates in dorsal root ganglia, causing an axonal neuronopathy. Symptoms include numbness, pain and gait disturbance which may…”
Get full text

Returning to work following curative chemotherapy: a qualitative study of return to work barriers and preferences for intervention by Knott, Vikki, Zrim, Stephanie, Shanahan, E. Michael, Anastassiadis, Peter, Lawn, Sharon, Kichenadasse, Ganessan, Sukumaran, Shawgi, Karapetis, Christos, Koczwara, Bogda

“…Purpose This study aimed to explore barriers to return to work (RTW) and preferences for intervention and support for cancer patients treated with curative…”
Get full text